In this piece, Fabio Gsaller discusses the mechanisms underpinning antifungal resistance in A. fumigatus and his work on the use of 5-flucytosine as a therapeutic agent in managing aspergillosis.
Several recent papers have investigated how polymicrobial interactions in the cystic fibrosis (CF) lung influence antimicrobial efficacy, demonstrating that microbial metabolites produced by one pathogen can alter the antimicrobial killing of another pathogen.
Human mobility and globalization have brought new invasive species to other countries. In terms of environment and nature, some of…
Widespread use of antibiotics in pregnancy to eradicate Group B Streptococcus has reduced disease in babies, however, could bacteriophage therapy yield the same results but in a more selective manner?
In this exclusive opinion piece, the authors discuss how ‘OMICS’ can help to unravel molecular dynamics driving the complex biological process involved in disease transmission.
In our new regular column, author, Julie Kaiser, highlights exciting developments in the field of AMR – this month read more about the origins of AMR genes and the ‘producer hypothesis’.
Chagas disease displays different parasitic stages, phases of disease and consequently special diagnostic needs, leading to underdiagnosis and further spread to non-endemic countries. Find out more in this exclusive piece.